20th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2021)8-10 November 2021, Muscat - Oman(Virtual meeting and on-site activities) Survey

It would help us in the planning of future meetings if you would be kind enough to complete this form.

Please tick the appropriate box and add any comments you may wish to make.

Question Title

* 1. Your gender

Question Title

* 2. Your details

Country of Activity

Type of affiliation

Question Title

* 3. Which group do you belong to?

Regulatory Authority

Commercial Organisation

Academic Institution

Public Health organisation

Other non-commercial Organisation

Student

Retired

Other (please specify)

Question Title

* 4. How many times have you attended an ISoP annual meeting?

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 5. Have you attended the on-site activities in Muscat?

Yes

Question Title

* 6. What is your general opinion of the meeting?

Very poor

Poor

Good

Excellent

Meeting arrangements

Question Title

* 7. What is your opinion of the information provided before the meeting?

Very poor

Poor

Good

Excellent

Comment (optional)

Question Title

* 8. What is your opinion of the practical arrangements for the meeting (website, registrations, satellite training courses, paperwork, timekeeping, etc)?

Very poor

Poor

Good

Excellent

Comment (optional)

Question Title

* 9. What is your opinion of the online platform? (Access, navigation, and content)

Very poor

Poor

Good

Excellent

Comment (optional)

Question Title

* 10. What is your opinion of the virtual poster sessions?

Very poor

Poor

Good

Excellent

Comment (optional)

Question Title

* 11. Your view of the on-site arrangements and evening hospitality programme (if attending the meeting locally)

Very poor

Poor

Good

Excellent

Comment (optional)

Content of the meeting

Question Title

* 12. Did you attend a satellite training course?

Yes

Question Title

* 13. If yes, please rate your experience of the training course

	Very Poor	Poor	Good	Excellent
Pharmacoepidemiological methods in PV	Pharmacoepidemiological methods in PV Very Poor	Pharmacoepidemiological methods in PV Poor	Pharmacoepidemiological methods in PV Good	Pharmacoepidemiological methods in PV Excellent
Managing safety signals in daily practice	Managing safety signals in daily practice Very Poor	Managing safety signals in daily practice Poor	Managing safety signals in daily practice Good	Managing safety signals in daily practice Excellent
PBRER Making and Assessment	PBRER Making and Assessment Very Poor	PBRER Making and Assessment Poor	PBRER Making and Assessment Good	PBRER Making and Assessment Excellent

Question Title

* 14. What are your views on having these courses online instead of face to face? What do you prefer and why?

Question Title

* 15. How useful was this Annual Meeting as a forum for you to discuss issues of current concern to you?

Very poor

Poor

Good

Excellent

Comment (optional)

Question Title

* 16. Please select your two most preferred keynote lectures from the following list:

Bengt-Erik Wiholm Lecture

CIOMS lecture: Results from CIOMS Working Group XI on patient involvement in the development and safe use of medicines

The pharmacovigilance system in Oman

Integrated pharmacovigiance for safer patients

Question Title

* 17. Please select your three most preferred sessions from the following list:

1A - Global post marketing safety surveillance of Covid-19 vaccines - planning and implementation (Part I)

1B - Global post marketing safety surveillance of Covid-19 vaccines-planning and implementation (Part II)

1C - Coordinating key stakeholders of national pharmacovigilance

1D - Harmonizing safety surveillance across different groups of health products (Part I)

1E - Harmonizing safety surveillance across different groups of health products (Part II)

1F - Integrating safety data and knowledge from different information sources

2A - Risks and benefits of medicines in pregnancy: a global update. (In collaboration with the ISoP Women’s Medicines Special Interest Group.)

2B - Incorporating new patient safety challenges into pharmacovigilance

2C - Trends in development of global regulatory frameworks for pharmacovigilance

2D - The Bengt-Erik Wiholm Lecture

2E - Promoting Patient Safety through Pharmacovigilance Infographics and Other Visuals

2F - Global pharmacovigilance: Hot topics from the ISoP regions

2G - ISoP General Assembly

3A - Combining local, regional and global perspectives in pharmacovigilance - increasing reliance

3B - Integrating pharmacovigilance monitoring of vaccines into national and international public health

3C - CIOMS lecture: Results from CIOMS Working Group XI on patient involvement in the development and safe use of medicines

3D - The pharmacovigilance system in Oman

3E - Keynote Lecture: Integrated pharmacovigilance for safer patients

3F - Poster prize awards and Closing remarks

Question Title

* 18. Were there any presentation or sessions which you found particularly irrelevant or uninteresting?

Question Title

* 19. Were there any topics missing from the agenda which you feel should have been included?
If yes, please write here:

Question Title

* 20. In planning for next year’s meeting, are there any issues or topics you feel should be included or arrangements which should be improved?
If yes, please write here:

Question Title

* 21. If English is not your first language, please could you say how the meeting could have been improved for you?

Question Title

* 22. Any other comments or suggestions?

Thank you very much!

Visit www.isoponline.org to keep up to date with ISoP activities

20th Annual Meeting of the International Society of Pharmacovigilance (ISoP 2021)8-10 November 2021, Muscat - Oman(Virtual meeting and on-site activities)

Question Title

* 1. Your gender

Question Title

* 2. Your details

Question Title

* 3. Which group do you belong to?

Question Title

* 4. How many times have you attended an ISoP annual meeting?

Question Title

* 5. Have you attended the on-site activities in Muscat?

Question Title

* 6. What is your general opinion of the meeting?

Question Title

* 7. What is your opinion of the information provided before the meeting?

Question Title

* 8. What is your opinion of the practical arrangements for the meeting (website, registrations, satellite training courses, paperwork, timekeeping, etc)?

Question Title

* 9. What is your opinion of the online platform? (Access, navigation, and content)

Question Title

* 10. What is your opinion of the virtual poster sessions?

Question Title

* 11. Your view of the on-site arrangements and evening hospitality programme (if attending the meeting locally)

Question Title

* 12. Did you attend a satellite training course?

Question Title

* 13. If yes, please rate your experience of the training course

Question Title

* 14. What are your views on having these courses online instead of face to face? What do you prefer and why?

Question Title

* 15. How useful was this Annual Meeting as a forum for you to discuss issues of current concern to you?

Question Title

* 16. Please select your two most preferred keynote lectures from the following list:

Question Title

* 17. Please select your three most preferred sessions from the following list:

Question Title

* 18. Were there any presentation or sessions which you found particularly irrelevant or uninteresting?

Question Title

* 19. Were there any topics missing from the agenda which you feel should have been included?If yes, please write here:

Question Title

* 20. In planning for next year’s meeting, are there any issues or topics you feel should be included or arrangements which should be improved?If yes, please write here:

Question Title

* 21. If English is not your first language, please could you say how the meeting could have been improved for you?

Question Title

* 22. Any other comments or suggestions?

20th Annual Meeting of the
International Society of Pharmacovigilance
(ISoP 2021)
8-10 November 2021, Muscat - Oman
(Virtual meeting and on-site activities)

* 19. Were there any topics missing from the agenda which you feel should have been included?
If yes, please write here:

* 20. In planning for next year’s meeting, are there any issues or topics you feel should be included or arrangements which should be improved?
If yes, please write here: